These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29479533)

  • 1. BIN1 localization is distinct from Tau tangles in Alzheimer's disease.
    De Rossi P; Buggia-Prevot V; Andrew RJ; Krause SV; Woo E; Nelson PT; Pytel P; Thinakaran G
    Matters (Zur); 2017 Jan; 2017():. PubMed ID: 29479533
    [No Abstract]   [Full Text] [Related]  

  • 2. Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts.
    De Rossi P; Buggia-Prévot V; Clayton BL; Vasquez JB; van Sanford C; Andrew RJ; Lesnick R; Botté A; Deyts C; Salem S; Rao E; Rice RC; Parent A; Kar S; Popko B; Pytel P; Estus S; Thinakaran G
    Mol Neurodegener; 2016 Aug; 11(1):59. PubMed ID: 27488240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology.
    Taga M; Petyuk VA; White C; Marsh G; Ma Y; Klein HU; Connor SM; Kroshilina A; Yung CJ; Khairallah A; Olah M; Schneider J; Karhohs K; Carpenter AE; Ransohoff R; Bennett DA; Crotti A; Bradshaw EM; De Jager PL
    Mol Neurodegener; 2020 Jul; 15(1):44. PubMed ID: 32727516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology.
    Holler CJ; Davis PR; Beckett TL; Platt TL; Webb RL; Head E; Murphy MP
    J Alzheimers Dis; 2014; 42(4):1221-7. PubMed ID: 25024306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer's disease.
    Thomas S; Prendergast GC
    Front Pharmacol; 2023; 14():1183932. PubMed ID: 37521457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice.
    Zhang X; Zou L; Tang L; Xiong M; Yan XX; Meng L; Chen G; Xiong J; Nie S; Zhang Z; Chen Q; Zhang Z
    PLoS Biol; 2024 Jan; 22(1):e3002470. PubMed ID: 38206965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Bin1 Promotes the Propagation of Tau Pathology.
    Calafate S; Flavin W; Verstreken P; Moechars D
    Cell Rep; 2016 Oct; 17(4):931-940. PubMed ID: 27760323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology.
    Adams SL; Tilton K; Kozubek JA; Seshadri S; Delalle I
    J Neuropathol Exp Neurol; 2016 Aug; 75(8):779-790. PubMed ID: 27346750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease.
    Thomas S; Hoxha K; Tran A; Prendergast GC
    J Cell Biochem; 2019 Oct; 120(10):18320-18331. PubMed ID: 31211444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain.
    Malki I; Cantrelle FX; Sottejeau Y; Lippens G; Lambert JC; Landrieu I
    FEBS J; 2017 Oct; 284(19):3218-3229. PubMed ID: 28755476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.
    McAvoy KM; Rajamohamed Sait H; Marsh G; Peterson M; Reynolds TL; Gagnon J; Geisler S; Leach P; Roberts C; Cahir-McFarland E; Ransohoff RM; Crotti A
    PLoS One; 2019; 14(8):e0220125. PubMed ID: 31408457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
    Su JH; Cummings BJ; Cotman CW
    Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease.
    Tan MS; Yu JT; Tan L
    Trends Mol Med; 2013 Oct; 19(10):594-603. PubMed ID: 23871436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains.
    Pearson AG; Byrne UT; MacGibbon GA; Faull RL; Dragunow M
    Neurosci Lett; 2006 May; 398(3):246-50. PubMed ID: 16481106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.